U.S. Entertainment Stock News

NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

How Definium’s Widening 2025 Loss Will Impact Definium Therapeutics (DFTX) Investors

Definium Therapeutics, Inc. reported full-year 2025 results on February 26, 2026, posting a net loss of US$183.79 million and a basic loss per share from continuing operations of US$2.06, both higher than the prior year. The widening loss highlights the financial strain of Definium’s development efforts even as it maintains visibility with investors through events like the TD Cowen Health Care Conference in Boston. We’ll now examine how this increased net loss shapes Definium Therapeutics’...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Is Marvell Technology (MRVL) Still Reasonably Priced After Recent Share Price Surge?

If you are wondering whether Marvell Technology at around US$89.57 still offers reasonable value, you are not alone, and the answer depends heavily on how you look at its valuation. The stock has seen sharp moves recently, with returns of 9.6% over the last 7 days, 20.7% over the last 30 days, 0.2% year to date, 26.9% over 1 year, 134.1% over 3 years and 93.8% over 5 years. These moves can change how the market prices its future potential and risk. Recent news flow has kept Marvell in focus,...
NYSE:MRSH
NYSE:MRSHInsurance

Peter Harrison Joins Marsh McLennan Board As Valuation Gap Persists

Marsh & McLennan Companies (NYSE:MRSH) has appointed Peter Harrison, former CEO of Schroders plc, to its Board of Directors. Harrison brings board and leadership experience from major global financial institutions and international business organizations. The appointment adds investment management and global governance expertise at a time of ongoing change in financial and risk markets. Marsh & McLennan sits at the intersection of risk, insurance brokerage, consulting, and...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

A Look At NetScout Systems (NTCT) Valuation As New DDoS Threat Report Draws Fresh Investor Attention

NetScout Systems (NTCT) is back in focus after its 2025 second half DDoS Threat Intelligence Report flagged more complex, coordinated cyberattacks, while a recent analysis highlighted the company’s balance sheet strength and apparent value profile. See our latest analysis for NetScout Systems. Those DDoS report headlines and value-focused write ups come against a backdrop of steadily improving momentum, with a 90 day share price return of 10.78% and a 1 year total shareholder return of 39.06%...
NYSE:BAX
NYSE:BAXMedical Equipment

Is Baxter International (BAX) Pricing In Too Much Bad News After Its Sharp Share Price Fall

Many investors are currently asking whether Baxter International's share price reflects its underlying value, as they watch how the stock is trading today. The shares last closed at US$17.69, after returns of a 13.2% decline over 7 days, a 15.9% decline over 30 days, a 9.3% decline year to date, and longer-term falls of 51.0% over 1 year, 50.2% over 3 years, and 74.8% over 5 years. Recent coverage on Baxter has focused on how the business is repositioning itself and responding to past...
NYSE:ELV
NYSE:ELVHealthcare

Elevance Health (ELV) Faces CMS MA Sanctions and Boosts Social Impact Efforts Is Its Model Evolving?

In late February and early March 2026, Elevance Health disclosed that CMS plans to sanction its Medicare Advantage-Prescription Drug plans over alleged risk adjustment data issues, while also announcing leadership changes at Carelon and supporting a national diaper access pilot with the National Diaper Bank Network. The combination of potential CMS enrollment sanctions in a key Medicare Advantage segment and Elevance’s expanded community health initiatives raises important questions about...
NasdaqGS:ADSK
NasdaqGS:ADSKSoftware

Assessing Autodesk (ADSK) Valuation After Strong Results And AI And Cloud Restructuring

Autodesk (ADSK) is back in focus after reporting fourth quarter and full year fiscal 2026 results that came in above the high end of its own guidance on revenue and margins, alongside a sizable restructuring toward AI and cloud. See our latest analysis for Autodesk. Autodesk’s share price is now US$260.99, with a 7 day share price return of 6.15% and a 30 day share price return of 7.22% after a softer 90 day patch. The 3 year total shareholder return of 34.52% suggests longer term holders...
NYSE:NVT
NYSE:NVTElectrical

A Look At nVent Electric (NVT) Valuation After Renewed Bullish Analyst Coverage And Upgrades

nVent Electric (NVT) is back in focus after a wave of favorable analyst actions, including new coverage with a positive rating and several upgrades or reiterated upbeat recommendations from major brokerage firms. See our latest analysis for nVent Electric. That upbeat analyst sentiment comes after a sharp pullback in the share price, with a 1-day share price return showing a 4.10% decline and a 7-day share price return showing a 10.43% decline, even as the 1-year total shareholder return sits...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Is Zevra Therapeutics (ZVRA) Pricing Reflect Its Strong DCF Upside Potential

If you are wondering whether Zevra Therapeutics is attractively priced or already reflects its potential, the starting point is to understand how the current share price compares to a range of valuation measures. The stock closed at US$8.98, with returns of 0.6% over the last 7 days, 0.4% over 30 days, 7.7% year to date and 10.9% over 1 year. Over 3 years the return is very large at around 2x, while the 5 year return is a 4.4% decline. Recent news coverage around Zevra has focused on its...
NYSE:JOBY
NYSE:JOBYAirlines

Why Joby Aviation (JOBY) Is Down 5.1% After Uber Dubai Air Taxi Deal And Surging Q4 Sales

Joby Aviation, Inc. reported fourth-quarter 2025 sales of US$30.84 million versus US$55,000 a year earlier, while reducing its quarterly net loss to US$121.54 million, and also announced a partnership with Uber to integrate its all‑electric air taxis into the Uber app for Dubai riders. The combination of rapidly growing early-stage revenue, a six-year exclusive air taxi agreement in Dubai, and app-based access via Uber highlights how Joby is beginning to commercialize its eVTOL ecosystem...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly Faces Actos RICO Class Action Test To Growth Story

A national class of third party payors has been certified in a RICO lawsuit tied to alleged concealment of bladder cancer risk associated with diabetes drug Actos. The case targets Eli Lilly (NYSE:LLY) alongside Takeda and could expose the company to material legal, financial and reputational risk across a wide group of U.S. insurers and payors. Class certification expands potential claimant participation and may influence how future liabilities and settlement discussions develop. Eli...
NasdaqGS:BKNG
NasdaqGS:BKNGHospitality

Booking Holdings’ AI Push Tests Role In Trip Planning And Payments

Booking Holdings is rolling out advanced AI agentic tools across brands like Booking.com, Priceline, and Agoda to respond to new platform-based travel search experiences. Company leadership, including the CFO, has highlighted stable direct traffic and played down concerns about being cut out by large AI platforms. External analysis points to Booking's role as merchant of record as a key factor in how it participates in AI-driven changes in online travel. For you as an investor looking at...
NYSE:VLTO
NYSE:VLTOCommercial Services

How Veralto’s Dividend Hike and Upbeat 2026 Outlook Could Shape VLTO Investors’ Expectations

Veralto Corporation recently announced that its board approved a quarterly cash dividend of US$0.13 per share, payable on April 30, 2026, to shareholders of record as of March 31, 2026. The dividend declaration follows Veralto’s fourth consecutive quarter of adjusted earnings beats and a 2026 outlook calling for continued growth in core sales and adjusted earnings per share. We will now examine how Veralto’s stronger-than-expected Q4 earnings and confident 2026 guidance interact with its...
NYSE:JEF
NYSE:JEFCapital Markets

Jefferies Lawsuit Puts Legal And Risk Management Practices In Focus

Western Alliance Bancorp has filed a high profile lawsuit against Jefferies Financial Group (NYSE:JEF) alleging breach of contract and fraud tied to a commercial loan connected to the bankrupt First Brands Group. The dispute centers on a loan that Jefferies reportedly charged off after First Brands Group entered bankruptcy. A law firm and the SEC are also investigating aspects of Jefferies' conduct and lending practices related to this matter. The combination of litigation, regulatory...
NYSE:CFG
NYSE:CFGBanks

Citizens Buys Matrix To Deepen Fee Income In Energy And Retail

Citizens Financial Group agreed to acquire substantially all assets of Matrix Capital Markets Group, a specialist advisor in downstream energy and convenience retail. The deal is intended to expand Citizens’ sector-focused advisory capabilities and deepen its presence in energy and retail markets. Matrix’s team is expected to join Citizens, adding expertise in mergers and acquisitions, capital advisory, and valuation services. Citizens Financial Group, traded as NYSE:CFG, is moving to...
NYSE:AES
NYSE:AESRenewable Energy

AES Take Private Deal Tests Debt Terms And Regulatory Risk For Investors

AES Corporation (NYSE:AES) has agreed to a proposed US$33b take private acquisition by a consortium including Global Infrastructure Partners, EQT, CalPERS, and Qatar Investment Authority. The deal would end AES’s status as a publicly traded company if completed, subject to regulatory and shareholder approvals. The transaction has drawn scrutiny from state officials, ratepayer advocates, and legislators who are focused on potential effects on customer bills, oversight, and foreign...
NYSE:PSX
NYSE:PSXOil and Gas

Does Phillips 66’s (PSX) Higher Dividend Reveal a Deeper Shift in Its Capital Allocation Priorities?

Earlier this week, Phillips 66 outlined its outlook at the Morgan Stanley Energy & Power Conference in New York, highlighting its diversified refining, midstream, and petrochemicals operations while also announcing a higher quarterly dividend of US$1.27 per share as part of its capital return plans. The combination of a dividend increase and management’s focus on sustainable cash flow and operational efficiency has drawn fresh attention to how Phillips 66 may benefit from tighter refining...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

A Look At Monster Beverage (MNST) Valuation After Strong Annual Results And Rising Investor Interest

Monster Beverage (MNST) is back in focus after its latest quarterly and full year report highlighted higher sales and net income, along with increased institutional interest that has pushed the stock sharply higher over the past year. See our latest analysis for Monster Beverage. Even after a strong 1 year total shareholder return of 37.3%, recent trading has cooled, with a 7 day share price return of 11.36% decline and a 30 day share price return of 7.16% decline, suggesting some momentum...
NYSE:DELL
NYSE:DELLTech

Assessing Dell Technologies (DELL) Valuation After Record AI Infrastructure Results And Higher Capital Returns

Dell Technologies (DELL) is back in focus after reporting record fiscal 2026 results, reflecting strong demand for AI servers and storage as well as new commitments to shareholder returns through a higher quarterly dividend and an expanded share repurchase authorization. See our latest analysis for Dell Technologies. The recent earnings beat, higher dividend and larger buyback sit against a strong run in the shares, with a 20.03% 1 month share price return and a very large 3 year total...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Nuvalent Expands Funding Flexibility As Valuation Discount Draws Investor Attention

Nuvalent (NasdaqGS:NUVL) filed a significant shelf registration, creating the option to raise fresh capital over time. The company also presented at a major healthcare conference, sharing updates on its oncology pipeline with investors and industry peers. For investors following biotech, these two moves highlight potential next steps for Nuvalent, a precision oncology company. Shelf capacity can be important in a sector where clinical programs, regulatory milestones and potential partnering...
NYSE:NAT
NYSE:NATOil and Gas

Assessing Nordic American Tankers (NAT) Valuation After Strong Q4 Results And Insider Buying

Nordic American Tankers (NAT) is in the spotlight after a stronger fourth quarter, fresh earnings, and increased insider buying. Management is highlighting fleet upgrades, operational efficiencies, and an ongoing focus on regular dividends. See our latest analysis for Nordic American Tankers. The latest earnings beat, insider buying and stronger tanker rates have come alongside a sharp 66.8% year to date share price return and a very strong 150.5% one year total shareholder return. This...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

FuboTV Drops PayPal What Payment Shift Could Mean For Investors

FuboTV (NYSE:FUBO) plans to discontinue PayPal as a payment method for subscribers. From April 2, 2026, users will need to pay via direct debit or credit card. The change affects both existing subscribers and new sign ups on the platform. FuboTV operates a sports focused live TV streaming service that competes with both traditional pay TV and other over the top providers. Payment infrastructure is a key part of that model, affecting how easily subscribers can join, manage their accounts,...
NYSE:OMF
NYSE:OMFConsumer Finance

A Look At OneMain Holdings (OMF) Valuation After New 2026 Auto Loan ABS Ratings

KBRA’s auto loan ABS move puts fresh attention on OneMain Holdings (OMF) KBRA’s preliminary ratings on notes from OneMain Direct Auto Receivables Trust 2026-1, the company’s first 2026 auto loan ABS deal with a three year revolving period, are putting fresh focus on OneMain Holdings (OMF) today. See our latest analysis for OneMain Holdings. At a share price of US$53.41, OneMain’s 1 month share price return of 15.49% decline and year to date share price return of 22.67% decline contrast with...
NasdaqGS:FBNC
NasdaqGS:FBNCBanks

Is First Bancorp (FBNC) Pricing Reflect Long Term Gains And Recent Regional Bank Repricing

If you are wondering whether First Bancorp's current share price reflects its true worth, you are not alone and that is exactly what this article will unpack. The stock trades at US$55.93, with a 7 day return of 1.5% decline, a 30 day return of 7.6% decline, and longer term returns of 9.9% year to date, 41.5% over 1 year, 56.4% over 3 years and 30.0% over 5 years that may have reshaped how investors view its potential and risk. Recent coverage of First Bancorp has focused on how investors...